Topic

dermatology

8 articles

Sligo nurse's 2 Dubai Derma 2026 talks put PRP governance on UAE clinic agenda

Claudia McGloin's Dubai Derma profile raises a practical UAE question: who should deliver PRP, and under which licence?

11 Oct 2026 · 3 min read

Sligo nurse's 2 Dubai Derma 2026 talks put PRP governance on UAE clinic agenda

14 O’Connor HS athletes treated for impetigo, raising UAE school-clinic response questions

A Texas impetigo cluster shows what UAE clinics, insurers and parents should check when school skin infections spread.

8 Oct 2026 · 3 min read

14 O’Connor HS athletes treated for impetigo, raising UAE school-clinic response questions

Dubai Derma 2026 puts AI dermoscopy before 25,000 visitors as skin checks move upmarket

Dubai Derma 2026 put AI dermoscopy into the skin cancer agenda. UAE clinics need evidence, consent and payer clarity before adoption.

10 Sept 2026 · 3 min read

Dubai Derma 2026 puts AI dermoscopy before 25,000 visitors as skin checks move upmarket

EDE approves once-daily Rinvoq for UAE vitiligo patients aged 12+

The UAE is the first market to approve oral Rinvoq for non-segmental vitiligo. Clinics and insurers now face pricing, eligibility and monitoring questions.

23 Aug 2026 · 3 min read

EDE approves once-daily Rinvoq for UAE vitiligo patients aged 12+

EDE approves once-daily RINVOQ for vitiligo patients aged 12+ in UAE

The UAE is first to approve oral RINVOQ for eligible non-segmental vitiligo. Clinics and insurers now need protocols, pricing checks and prior authorisation rules.

21 Aug 2026 · 3 min read

EDE approves once-daily RINVOQ for vitiligo patients aged 12+ in UAE

EDE approves Rinvoq for vitiligo patients aged 12+ as UAE clinics face AED 5,789 monthly drug cost

The UAE approved once-daily Rinvoq for non-segmental vitiligo. Clinics, insurers and patients now face eligibility, monitoring and coverage decisions.

21 Aug 2026 · 3 min read

EDE approves Rinvoq for vitiligo patients aged 12+ as UAE clinics face AED 5,789 monthly drug cost

UAE approves Rinvoq for vitiligo in patients 12+ as first oral systemic option

EDE approved once-daily Rinvoq for eligible non-segmental vitiligo patients. Clinics need prescribing, price and insurance checks.

20 Aug 2026 · 3 min read

UAE approves Rinvoq for vitiligo in patients 12+ as first oral systemic option

UAE approves Rinvoq for vitiligo patients aged 12+, creating first country-level oral licence

Rinvoq is now approved in the UAE for eligible non-segmental vitiligo patients. Clinics and insurers must prepare for systemic therapy demand.

18 Aug 2026 · 3 min read

UAE approves Rinvoq for vitiligo patients aged 12+, creating first country-level oral licence